Emergency Use Of Covid 19 Vaccine
- All
- News
-
Novavax's Covid Vaccine Gets Emergency Use Nod For Kids Aged 12-17 In India
Novavax Inc said on Tuesday its COVID-19 vaccine has got emergency-use authorization from the Drugs Controller General of India for children aged 12 to 17 years.
-
Who Will Get Covid Vaccine First, How To Register: All You Need To Know
India's drugs regulator has approved Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country. This paves the way for the roll out of at least two vaccines in India in the coming days.
-
Novavax's Covid Vaccine Gets Emergency Use Nod For Kids Aged 12-17 In India
Novavax Inc said on Tuesday its COVID-19 vaccine has got emergency-use authorization from the Drugs Controller General of India for children aged 12 to 17 years.
-
Who Will Get Covid Vaccine First, How To Register: All You Need To Know
India's drugs regulator has approved Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country. This paves the way for the roll out of at least two vaccines in India in the coming days.
